Health literacy and consumer-centred care: at the brink of change?
Towards a stronger medicare
Membership report card June 2015
Pharmacists and Primary Health Care Consumer Survey Report
The major implication of these results for health policymakers is that defenders of traditional “silos” of medicine need to rethink what ought to be considered traditional roles for GPs and pharmacists. Moreover, if pharmacists are going to assume a greater role in the provision of primary care services, then the industry is going to have to think through what training and accommodation will be necessary to give consumers the confidence that these services do not compromise the quality they have come to expect from GPs.
Submission to RACGP Paper: Vision for a Sustainable Health System
Abstract: CHF's submission to the RACGP's Vision for a Sustainable Health System Discussion Paper.
“Unique and essential”: a review of the role of consumer representatives in health decision-making
Submission on the Issues Paper for the Post-market Review of the Life Saving Drugs Programme
The Consumers Health Forum of Australia (CHF) is pleased to provide a submission to the Issues Paper for the Post-Market Review of the Life-Saving Drugs Programme (the Issues Paper). Before going into the content of our views, we want to express our deep concerns with the limitations the Review has given to stakeholders to comment on the Issues Paper.
CHF's First Views on Budget 2015-16
This is an initial analysis of the Federal Health Budget from the Consumers Health Forum of Australia (CHF). There is further detail in the Budget papers that require further appraisal before CHF takes a view on these aspects. We are preparing a more detailed analysis based on further briefings and consultations.
Health Voices, Issue 16, April 2015
PHNs... Will they be good for our health?
Submission to the Senate Community Affairs References Committee Inquiry into the Availability of new, innovative and specialist cancer drugs in Australia
This submission into the Availability of new, innovative and specialist cancer drugs in Australia draws on the experiences of our members and consumer representatives in assessing the availability and effectiveness of medicines in Australia, and in particular the operation of the Pharmaceutical Benefits Advisory Committee (PBAC) and the Pharmaceutical Benefits Scheme (PBS).